Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 13, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) and Graceway Pharmaceuticals, LLC., (based in Bristol, TN) today announced that they have entered into an agreement to settle all existing patent...
-
Apr 8, 2010
Perrigo Company of South Carolina, Inc. (NASDAQ: PRGO)(TASE: PRGO) announced today that it won two favorable jury verdicts against Rexall Sundown, Inc. in an unfair competition lawsuit that was...
-
Apr 5, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, together with its partner Cobrek Pharmaceuticals, Inc., it has agreed to settle all Hatch-Waxman litigation relating to...
-
Apr 5, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration...
-
Mar 23, 2010
-- PBM Holdings is the world's largest manufacturer and marketer of infant formulas for the store brand market -- All cash transaction with a purchase price of $808 million -- Acquisition expected...
-
Mar 15, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has begun shipping Ketotifen Fumarate ophthalmic solution, 0.025%, a generic version of Zaditor™. Zaditor™ is a sterile...
-
Mar 1, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has signed a definitive purchase agreement to acquire Orion Laboratories Pty, Ltd. for approximately $48 million in cash. Based...
-
Feb 18, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Ciclopirox Shampoo, 1%, a...
-
Feb 12, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600...
-
Feb 2, 2010
-- Fiscal second quarter revenue from continuing operations increased $46 million, or 9%, to $583 million -- Fiscal second quarter adjusted income from continuing operations increased 56% to $65...